Valuation: Avantor, Inc.

Capitalization 5.44B 4.62B 4.23B 3.99B 7.44B 518B 7.5B 50.15B 19.58B 247B 20.42B 19.99B 854B P/E ratio 2026 *
23.1x
P/E ratio 2027 * 18.7x
Enterprise value 8.45B 7.17B 6.57B 6.19B 11.55B 805B 11.65B 77.91B 30.41B 384B 31.72B 31.05B 1,327B EV / Sales 2026 *
1.3x
EV / Sales 2027 * 1.18x
Free-Float
95.58%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 17/08/2025
Director of Finance/CFO 56 06/08/2023
Chief Operating Officer - 09/11/2025
Director TitleAgeSince
Director/Board Member 60 21/04/2020
Chairman 69 31/12/2025
Director/Board Member 62 30/09/2021
Change 5d. change 1-year change 3-years change Capi.($)
-4.09%-0.25% - - 5.44B
-2.09%-5.69%-38.04%-24.98% 144B
-2.11%-4.80%-10.71%-16.27% 95.7B
+0.18%-0.82%+53.89%+78.33% 58.02B
-0.53%-14.48%-8.23%+51.48% 50.53B
-4.20%-2.16%-14.39%-43.06% 39.44B
-0.68%-11.18% - - 33.19B
-2.11%-1.18%-29.93%-51.00% 22.89B
-1.11%+7.37%+51.27%-10.50% 22.77B
-2.70%-4.90%-10.86%-2.96% 19.8B
Average -1.94%-3.67%-0.87%-2.37% 49.16B
Weighted average by Cap. -1.74%-5.07%-9.02%-2.57%

Financials

2026 *2027 *
Net sales 6.5B 5.52B 5.05B 4.76B 8.88B 619B 8.96B 59.91B 23.38B 295B 24.39B 23.88B 1,021B 6.64B 5.63B 5.16B 4.86B 9.07B 632B 9.14B 61.15B 23.87B 301B 24.9B 24.37B 1,042B
Net income 235M 199M 182M 172M 321M 22.37B 323M 2.16B 845M 10.65B 881M 862M 36.87B 291M 247M 226M 213M 397M 27.7B 401M 2.68B 1.05B 13.19B 1.09B 1.07B 45.66B
Net Debt 3.01B 2.56B 2.34B 2.21B 4.12B 287B 4.15B 27.76B 10.84B 137B 11.3B 11.06B 473B 2.36B 2.01B 1.84B 1.73B 3.23B 225B 3.26B 21.78B 8.5B 107B 8.87B 8.68B 371B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
11/05/26 7.970 $ -4.09% 6,731,114
08/05/26 8.310 $ 0.00% 14,978,176
07/05/26 8.310 $ -1.42% 11,258,348
06/05/26 8.430 $ +4.72% 8,140,729
05/05/26 8.050 $ +0.75% 5,471,283
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
7.970USD
Average target price
9.923USD
Spread / Average Target
+24.51%

Quarterly revenue - Rate of surprise